We are proud to be a finalist for the award of ‘Scale-up de l’Année – Scale-up of the Year 2022,’ a prestigious award presented by EY Belgium in collaboration with BNP Paribas Fortis and l’Echo.
The Scale-up de l’Année award is in its 10th year, recognizing rapidly growing companies in the midst of their development phase that have great potential in terms of innovation, entrepreneurship, strategy, openness to the world and perseverance. Cognivia has been named a finalist alongside Aerospacelab, AppTweak, and EMAsphere.
“Thank you to the awards committee for recognizing our growth potential with our innovative solutions,” said CEO Dominique Demolle, PhD. “2022 has been a fantastic year for Cognivia. We started the year by rebranding to Cognivia and expanding our Board of Directors. We also have dramatically broadened the application of Placebell, our first predictive tool and enlarged our portfolio with other very innovative predictive technologies of patient s’ behavior. This recognition will conclude this year of remarkable successes!”
This evolution and expansion underpin Cognivia’s core mission: to accelerate patient access to new therapies and improve patients’ lives by developing and commercializing data analysis solutions focused on the unique patient characteristics that influence their response to treatment. Most recently, CEO Dr. Dominique Demolle, PhD, was named among 2022’s most inspiring people by PharmaVoice for propelling Cognivia to where it is today.
With the Placebell©™ approach proven, other solutions in development (for example, prediction of patient non-compliance and drop out), and a growing expert team, Cognivia is looking forward to scale and deliver more next-gen solutions to the clinical trials space. It is an honor to be recognized in this way – and congratulations to the other finalist companies for their recognition.
The awards ceremony will be hosted on December 5 where the winner will be announced. Learn more here.